---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-22-000474"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2022-04-26T23:59:59+00:00"
generated_at: "2026-06-26T04:53:48.289286+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# USANA Q1 net sales $273M (-11% YoY), EPS $1.15 (-21% YoY); cuts FY2022 guidance

## Summary
- Net sales $272.9M, down 11% YoY; diluted EPS $1.15, down 21% from $1.45.
- Asia Pacific net sales $218.4M (-13% YoY); Greater China down 10%; Southeast Asia Pacific down 24%.
- Active customers 552,000, down 11% YoY; Americas & Europe active customers down 10%.
- Revised FY2022 outlook: net sales $1.1-1.2B (was $1.125-1.225B), EPS $5.00-5.70 (was $5.25-6.00).
- Company repurchased $25M in shares in Q1; $83M remaining under authorization; cites China COVID lockdowns as headwind.

## SEC filing metadata
- accession: 0001157523-22-000474
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2022-04-26T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000115752322000474/0001157523-22-000474-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000115752322000474/a52698273.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-22-000474
- JSON: https://secwatch.observer/filing/0001157523-22-000474.json
- Plain text: https://secwatch.observer/filing/0001157523-22-000474.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.